AtaiBeckley and PsyPAN Receive a Silver Award in 2026 Patient Participant Index, Reflecting Ongoing Commitment to Participant-Informed ResearchNEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- AtaiBeckley Inc. (
NASDAQ: ATAI) (“AtaiBeckley” or “Company”), a clinical-stage biotechnology company on a mission to transform patient outcomes by developing rapid-acting, durable and convenient mental health treatments, today announced it has received the Silver Award in OVID Health’s 2026 Patient Participant Index (PPI), in collaboration with the Psychedelic Participant Advocacy Network (PsyPAN), in recognition of their joint efforts to strengthen participant partnership in psychedelic clinical research. The recognition highlights AtaiBeckley’s multiyear collaboration with PsyPAN to integrate the lived experiences of clinical trial participants into the responsible development of novel mental health therapies and amplify these learnings across the sector.
FTI Consulting Appoints Mike Davies to Capital Markets PracticeLONDON, April 27, 2026 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (
NYSE: FCN) today announced the appointment of Mike Davies as a Senior Managing Director within the firm’s Strategic Communications segment.
Lumissil Introduces IS32LT3136 32-Channel Linear LED Driver for Next-Generation Automotive OLED LightingDevice brings fine channel control with UART networking, EMI mitigation, diagnostics, and ASIL-B functionality to animated OLED rear lamps, taillights, and DRL lighting
Veson and Veracity by DNV partner to streamline verified emissions reporting and commercial voyage managementA product integration between Veracity by DNV and Veson’s IMOS connects verified emissions data with core operational workflows
Fangzhou Publishes 2025 Annual Report, Advancing AI-Powered Chronic Care Strategy for 2026SHANGHAI, April 27, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI-driven Internet healthcare solutions, published its 2025 Annual Report, following the announcement of its 2025 annual results on March 19, 2026. The report highlights strong revenue growth, a return to full-year profitability and continued execution of Fangzhou’s “AI + chronic care” strategy as the Company advances its position as a trusted, long-term healthcare service partner for chronic disease patients across China. Revenue rose 30.2% year on year to RMB 3.53 billion, while net profit reached RMB 12 million, highlighting improving operating leverage. This performance underscores the resilience and scalability of Fangzhou’s business model and provides a solid foundation for further investment in AI-enabled chronic disease services and platform upgrades.
Stablecoin Cross-border B2B Transactions to Reach $5 Trillion by 2035, Causing Disruption to Correspondent Banking ChannelsBASINGSTOKE, United Kingdom, April 27, 2026 (GLOBE NEWSWIRE) -- A new study from global tech strategists Juniper Research has found the total value of cross-border B2B stablecoin transactions will reach $5 trillion by 2035, from $13.4 billion in 2026.
WeRide and Lenovo Collaborate to Deploy 200,000 Autonomous Vehicles Globally Over Five YearsBEIJING, April 27, 2026 (GLOBE NEWSWIRE) -- WeRide (NASDAQ: WRD, HKEX: 0800), a global leader in autonomous driving technology, announced an expanded collaboration with Lenovo (HKSE: 0992) at Auto China 2026 to accelerate the large-scale commercialization of Level 4 autonomous driving worldwide. Starting 2026, the two companies expect to jointly deploy 200,000 autonomous vehicles (AVs), including Robotaxis, globally over the next five years, marking one of the industry’s most ambitious efforts to scale autonomous mobility.
OSE Immunotherapeutics Welcomes FDA Orphan Drug Designation Granted to Pegrizeprument (VEL-101) for Prevention of Organ Rejection in Heart Transplant PatientsNantes, France, April 27, 2026 – 7:30am CEST - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), today welcomes the announcement by its partner Veloxis Pharmaceuticals, Inc. that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to pegrizeprument (VEL‑101) for the prophylaxis of heart allograft rejection in patients receiving a heart transplant. This follows the recent ODD granted in January 2026 for prevention of organ rejection in patients receiving a liver transplant.
Apollo Funds to Acquire Forvia’s Automotive Interiors BusinessTransaction to Establish Leading Global Automotive Interiors Supplier as Standalone Company
Four Models Assemble at Exclusive Preview Event as Global Partners Witness EXEED’s Premium Strategy Reach New HeightsBEIJING, April 27, 2026 (GLOBE NEWSWIRE) -- On April 23, EXEED hosted a new vehicle preview event, gathering over 100 partner representatives and industry guests from key global markets including Europe, the Middle East and Southeast Asia. The brand unveiled four new models in a concentrated showcase: the ES GT, ET8 CONCEPT, RX FL, and RX CONCEPT. From the TX’s debut at the 2017 Frankfurt Motor Show, to the RX earning trust as a benchmark with five-star safety ratings in Europe, Australia and China, and the ES and ET embracing electrification via Texxeract technology — the four models launched this time embody EXEED’s latest cutting-edge technologies and design language, while carrying forward the brand’s decade-long, steady evolution.
Santhera Receives Positive CHMP Opinion to Expand AGAMREE® (vamorolone) Use in Pediatric DMD Patients Aged Two and Older in the EUPratteln, Switzerland, April 27, 2026 – Santhera Pharmaceuticals (SIX: SANN) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending an extension to the marketing authorization for AGAMREE® (vamorolone) to include the treatment of patients with Duchenne muscular dystrophy (DMD) from 2 years of age.
ISS extends and expands contract with the Fulham Road Collaborative in the UKISS, a leading global workplace experience and facility services company, has further strengthened its partnership with the Fulham Road Collaborative (FRC) in the UK, comprising of Chelsea and Westminster Hospital NHS Foundation Trust and The Royal Marsden NHS Foundation Trust. The expanded scope of the contract has an annual value of approximately DKK 100 million.
NNOX Investors Have Opportunity to Join Nano-X Imaging Ltd. Fraud Investigation with the Schall Law FirmLOS ANGELES, April 26, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Nano-X Imaging Ltd. (“Nano-X” or “the Company”) (
NASDAQ: NNOX) for violations of the securities laws.
SRAD Investors Have Opportunity to Join Sportradar Group AG Fraud Investigation with the Schall Law FirmLOS ANGELES, April 26, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sportradar Group AG (“Sportradar” or “the Company”) (
NASDAQ: SRAD) for violations of the securities laws.
XXI Investors Have Opportunity to Join Twenty One Capital, Inc. Fraud Investigation with the Schall Law FirmLOS ANGELES, April 26, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Twenty One Capital, Inc. (“Twenty One Capital” or “the Company”) (
NYSE: XXI) for violations of the securities laws.
BMI Investors Have Opportunity to Join Badger Meter, Inc. Fraud Investigation with the Schall Law FirmLOS ANGELES, April 26, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Badger Meter, Inc. (“Badger” or “the Company”) (
NYSE: BMI) for violations of the securities laws.
ETS Investors Have Opportunity to Join Elite Express Holding Inc. Fraud Investigation with the Schall Law FirmLOS ANGELES, April 26, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elite Express Holding Inc. (“Elite Express” or “the Company”) (
NASDAQ: ETS) for violations of the securities laws.
DXST Investors Have Opportunity to Join Decent Holding Inc. Fraud Investigation with the Schall Law FirmLOS ANGELES, April 26, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Decent Holding Inc. (“Decent” or “the Company”) (
NASDAQ: DXST) for violations of the securities laws.
CUPR Investors Have Opportunity to Join Cuprina Holdings (Cayman) Limited Fraud Investigation with the Schall Law FirmLOS ANGELES, April 26, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cuprina Holdings (Cayman) Limited (“Cuprina” or “the Company”) (
NASDAQ: CUPR) for violations of the securities laws.
ZONE Investors Have Opportunity to Join CleanCore Solutions, Inc. Fraud Investigation with the Schall Law FirmLOS ANGELES, April 26, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CleanCore Solutions, Inc. (“CleanCore” or “the Company”) (NYSE American: ZONE) for violations of the securities laws.
APUS Investors Have Opportunity to Join Apimeds Pharmaceuticals US, Inc. Fraud Investigation with the Schall Law FirmLOS ANGELES, April 26, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Apimeds Pharmaceuticals US, Inc. (“Apimeds” or “the Company”) (NYSE American: APUS) for violations of the securities laws.
Louvre Furnishings Group’s Global Home Carnival Gains Momentum, Blending Trade, Culture and Holiday PromotionsFOSHAN, China, April 26, 2026 (GLOBE NEWSWIRE) -- The 2026 Global Home Carnival hosted by Louvre Furnishings Group is underway in Foshan, offering a 21-day program that combines international trade, cultural exchange and consumer promotions. Held alongside the Canton Fair and running through the May Day holiday, the event aims to attract global buyers while boosting seasonal consumption.
Oruka Therapeutics to Host Conference Call to Report Week 16 Data for ORKA-001 from the Ongoing EVERLAST-A Trial on April 27, 2026MENLO PARK, Calif., April 26, 2026 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a clinical-stage biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases, today announced it will report Week 16 data for ORKA-001 from the ongoing EVERLAST-A Phase 2a trial in moderate-to-severe plaque psoriasis on Monday, April 27, 2026. Following the announcement, the company will host a conference call and webcast at 8:00 a.m. ET to discuss the results.
Law Firm’s IP Monday Blog Highlights Innovation, Protection and StrategyLansing, Mich., April 26, 2026 (GLOBE NEWSWIRE) -- Today is World Intellectual Property (IP) Day, a chance to highlight the role of IP rights which include patents, trademarks, copyrights, and industrial designs to encourage innovation, protect creators, and contribute to economic and cultural development.
JETOUR Advances "Travel⁺" Strategy: Dual Brands Showcase at Auto China 2026BEIJING, April 26, 2026 (GLOBE NEWSWIRE) -- JETOUR International officially unveiled its "Travel⁺" strategy at the 2026 Beijing International Automotive Exhibition (Auto China 2026). JETOUR and SOUEAST made their first joint appearance and showcased a full-scenario product matrix and hardcore hybrid off-road technologies, comprehensively presenting their achievements in global operations . Over 1200 global dealers, media and KOLs attended the “Travel+” strategy launch event.
Study Shows Implicity’s New Agnostic Cloud-Based AI Algorithm Further Reduces False Alerts Even After Manufacturer AI Filtering in Modern DevicesNew HRS data extends EHRA findings with a specific analysis of next-gen ILRs, demonstrating that, on top of manufacturer-embedded AI, Implicity filters out 61.6% of false positives while maintaining 98.3% sensitivity
From Next-Generation Mobility to Global Expansion: iCAUR Demonstrated Its Vision at Beijing Auto Show 2026BEIJING, April 25, 2026 (GLOBE NEWSWIRE) -- The Beijing Auto Show 2026, which opened on April 24, marked a key moment for Chery Group’s iCAUR as the brand presented two major highlights: the ROBOX concept car and the right-hand-drive (RHD) version of the V27. Both were presented by Dr. Su Jun, CEO of iCAUR.
CGTN: The Art of Governance: How China is shaping a new path for sustainable developmentBEIJING, April 25, 2026 (GLOBE NEWSWIRE) -- As the world grapples with achieving sustainable economic growth, China is successfully using technology to boost people's livelihoods while also preserving the environment.
Fairfax Announces Conference CallTORONTO, April 24, 2026 (GLOBE NEWSWIRE) -- Fairfax Financial Holdings Limited (TSX: FFH and FFH.U) will hold a conference call at 8:30 a.m. Eastern Time on Friday, May 1, 2026 to discuss its 2026 first quarter results, which will be announced after the close of markets on Thursday, April 30, 2026 and will be available at that time on its website at www.fairfax.ca. The call, consisting of a presentation by the company followed by a question period, may be accessed at 1 (800) 369-2143 (Canada and U.S.) or 1 (312) 470-0063 (International) with the passcode “FAIRFAX”.
Rivalry Announces Board and Management ChangesTORONTO, April 24, 2026 (GLOBE NEWSWIRE) -- Rivalry Corp. (TSXV: RVLY) (the “Company” or “Rivalry”) today announced changes to its board of directors and management as part of the Company’s ongoing operational transition.
BGIN BLOCKCHAIN LIMITED Reports Unaudited Financial Results for the Full Year of 2025SINGAPORE, April 25, 2026 (GLOBE NEWSWIRE) -- BGIN BLOCKCHAIN LIMITED (“BGIN” or the “Company”; NASDAQ: BGIN), a digital asset technology company with proprietary cryptocurrency mining technologies and a manufacturer of cryptocurrency mining hardware, today released its unaudited financial results for the year ended December 31, 2025.
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NOVATO, Calif., April 24, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (
NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases, today reported the grant of 36,447 restricted stock units of the company’s common stock to 12 newly hired non-executive officers of the company. The awards were approved by the compensation committee of the company’s board of directors and granted under the Ultragenyx Employment Inducement Plan, with a grant date of April 16, 2026, as an inducement material to the new employees entering into employment with Ultragenyx in accordance with Nasdaq Listing Rule 5635(c)(4).
Park Dental Partners Announces Dates for First Quarter 2026 Earnings Release and Conference CallMINNEAPOLIS, April 24, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (
NASDAQ: PARK), a leading dental resource organization, today announced that it will report its financial results for the quarter ended March 31, 2026 after market close on Wednesday, May 13, 2026.The Company will host a conference call to discuss these results the next day on Thursday, May 14, 2026, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time).
Ebang International Reports Financial Results for Fiscal Year 2025IRVING, Texas, April 24, 2026 (GLOBE NEWSWIRE) -- Ebang International Holdings Inc. (Nasdaq: EBON, the “Company,” “we” or “our”), today announced its financial results for the fiscal year ended December 31, 2025.
Crescent Biopharma Announces Grants of Inducement AwardsWALTHAM, Mass., April 24, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that the independent Compensation Committee of its Board of Directors approved the grant of options to purchase an aggregate of 12,525 shares of the Company’s ordinary shares to two non-executive employees as equity inducement awards under the Crescent Biopharma, Inc. 2025 Employment Inducement Incentive Award Plan, as amended (the “Inducement Plan”). The options were approved on April 23, 2026 and were material to each employee's acceptance of employment with Crescent, in accordance with Nasdaq Listing Rule 5635(c)(4).
UTStarcom Files 2025 Form 20-FHANGZHOU, China, April 24, 2026 (GLOBE NEWSWIRE) -- UTStarcom (“UT” or the “Company”) (
NASDAQ: UTSI), a global telecommunications infrastructure provider, today filed its Annual Report on Form 20-F for the year ended December 31, 2025 with the U.S. Securities and Exchange Commission.
Altus Group Announces Completion of Substantial Issuer BidTORONTO, April 24, 2026 (GLOBE NEWSWIRE) -- Altus Group Limited (“Altus Group”) (TSX: AIF), a leading provider of commercial real estate (“CRE”) intelligence, today announced that it has taken up and paid for 3,846,153 of its common shares (“Shares”) at a price of C$52.00 per Share (the “Purchase Price”) under Altus Group’s substantial issuer bid (the “SIB”) to repurchase for cancellation a number of its Shares for an aggregate purchase price not to exceed C$200 million.
Middlesex Water Company Declares Quarterly Cash DividendISELIN, N.J., April 24, 2026 (GLOBE NEWSWIRE) -- Middlesex Water Company (
NASDAQ: MSEX) announced today that its Board of Directors has declared a quarterly cash dividend of $0.36 per share on its common stock, payable June 1, 2026 to shareholders of record as of May 15, 2026. Middlesex has paid cash dividends in varying amounts continually since 1912.
FDA Accelerates Action on Treatments for Serious Mental Illness Following Executive OrderAgency issues priority vouchers, clears new clinical research, and advances guidance to support treatments for depression, PTSD, and substance use disorders
Delaware Chancery Court Rules in Favor of Anaptys by Dismissing Tesaro’s Anticipatory Breach ClaimSAN DIEGO, April 24, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a company focused on managing the financial collaborations for Jemperli with GSK and imsidolimab with Vanda, today announced that the Delaware Chancery Court has dismissed Tesaro’s anticipatory breach of contract claim against Anaptys. The ruling agrees with Anaptys’ position that it has never repudiated the Collaboration and Exclusive License Agreement (“Collaboration Agreement”) with Tesaro, a subsidiary of GSK, governing the development and commercialization of Jemperli.
SBA Sends 562,000 Suspected Fraudulent Loans to Treasury for Collections Totaling $22 BillionWhite House Task Force to end Biden Administration amnesty for fraudulent pandemic-era loans, pursue historic collection
Biotech startup Plopii Files US Patent on the Next-Generation Headache PillBrooklyn biotech files 40-claim patent application covering a new active-ingredient combination for over-the-counter headache relief
The Deal Closers Expands Deployment of Its Done-For-You Client Acquisition System Across U.S. Tax Advisory FirmsNew York, NY, April 24, 2026 (GLOBE NEWSWIRE) -- The Deal Closers, a U.S.-based marketing and sales execution firm, announced the continued expansion of its proprietary client acquisition system across firms operating specifically in the tax planning and advisory space.
Gemini to Announce First Quarter 2026 Results on May 14, 2026NEW YORK, April 24, 2026 (GLOBE NEWSWIRE) -- Gemini Space Station, Inc. (“Gemini”) (
NASDAQ: GEMI), a global crypto and prediction markets platform, today announced it will release its first quarter 2026 financial results after market close on Thursday, May 14, 2026. Management will host a conference call on Friday, May 15, 2026 at 8:30 a.m. ET to discuss the results.
SEGG Media Enters Sports Predictions Market via Sports.com PredictFORT WORTH, Texas, April 24, 2026 (GLOBE NEWSWIRE) -- Sports Entertainment Gaming Global Corporation (NASDAQ: SEGG, LTRYW) (the “Company” or “SEGG Media”) today announced the launch of Sports.com Predict, marking the Company’s entry into the rapidly growing prediction markets space. The initiative will be developed and operated through Sports Predicts Limited, a SEGG Media company, and integrated into the Sports.com platform.
ComfyUI Raises $30M at $500M Valuation to Scale Open-Source AI for Creative ProductionOpen-source AI workflow platform surpasses 4M users and 50K daily downloads as investors back creator-first infrastructure
Bragar Eagel & Squire, P.C. Urges ChowChow Cloud International Holdings Limited Investors to Contact the Firm Before May 12thBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In CHOW To Contact Him Directly To Discuss Their Options
Mount Sinai Health System and Guyana Ministry of Health Host Seminar on Practical, Responsible Integration of Artificial Intelligence in Health CareGeorgetown, Guyana, April 24, 2026 (GLOBE NEWSWIRE) -- The Mount Sinai Health System and the Guyana Ministry of Health yesterday convened government, clinical, operational, and artificial intelligence (AI) leaders for a seminar, “Turning Promise Into Practice: Integrating AI Into Health Care—Foundations, Ethics, and Decision-Making,” in Georgetown, Guyana.
